The era of prostate-specific membrane antigen (PSMA)-based theranostics for hepatocellular carcinoma is upcoming: are we ready for it?
Luca FilippiArthur J BraatOrazio SchillaciPublished in: European journal of nuclear medicine and molecular imaging (2022)